Nonvalvular cardiovascular device-related infections.
暂无分享,去创建一个
Walter R Wilson | Larry M Baddour | A. Jacobs | M. Bettmann | A. Bolger | J. Newburger | R. Baltimore | L. Baddour | S. Shulman | K. Taubert | W. Wilson | P. Ferrieri | M. Gerber | A. Epstein | Alice K Jacobs | Jane W Newburger | Kathryn A Taubert | Ann F Bolger | Stanford T Shulman | Michael A Gerber | Michael H Gewitz | Lloyd Y Tani | Robert S Baltimore | Matthew E Levison | Thomas J Pallasch | Donald A Falace | Michael A Bettmann | Andrew E Epstein | Patricia Ferrieri | M. Levison | M. Gewitz | L. Tani | T. Pallasch | D. Falace
[1] Walter R Wilson,et al. Nonvalvular Cardiovascular Device–Related Infections , 2003, Circulation.
[2] M. Bell. Biofilms: A clinical perspective , 2001, Current infectious disease reports.
[3] R. Donlan. Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. Höök,et al. The Fibronectin-binding MSCRAMM FnbpA ofStaphylococcus aureus Is a Bifunctional Protein That Also Binds to Fibrinogen* , 2000, The Journal of Biological Chemistry.
[5] A. Bolger,et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] M A Gerber,et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. , 1990, JAMA.
[7] L. Baddour,et al. Pathogenesis of Infective Endocarditis , 2002 .
[8] J. Schwartzman,et al. Molecular medical microbiology , 2002 .